– Synapse® 3D is equipped with specialized technology which identifies three optimal paths leading to a lung lesion.
– Synapse 3D offers high-resolution imaging, intuitive navigation, and comprehensive analysis tools which helps in better yield and timely diagnosis.
– From volumetric measurements to nodule characterization, the Synapse 3D offers a comprehensive suite of analysis tools designed to support accurate diagnosis and treatment planning.
FUJIFILM India, a global leader in healthcare technology, proudly introduced its latest innovation in lung navigation – Synapse 3D, during the prestigious ABIP (Amrita Bronchoscopy & Interventional Pulmonology) event held in Kochi on 12th of May. Synapse 3D represents a groundbreaking advancement in pulmonary imaging and diagnostics. Leveraging state-of-the-art 3D technology, this device offers unparalleled precision and insight into pulmonary conditions, empowering healthcare professionals with the tools they need to deliver optimal patient care.
The Amrita Bronchoscopy & Interventional Pulmonology (ABIP) event served as a prominent platform for industry leaders, healthcare professionals, and innovators to convene and exchange insights on the latest advancements in pulmonary care. With a focus on interventional techniques and emerging technologies, the event facilitated discussions, workshops, and live demonstrations, providing attendees with valuable opportunities to enhance their knowledge and expertise in the field.
Synapse® 3D is equipped with specialized technology that identifies three optimal paths leading to a lung lesion. With the help of radial EBUS, the doctor can have better yield which ultimately helps in precise diagnosis for timely intervention. A bronchoscope simulation is performed along the path, helping to visualize difficult procedures before performing an invasive exam. This will not only help in navigating the right path in lungs, but also save time and less discomfort to the patient with better diagnosis.
Mr Dheeraj Chaudhri, Head of Endoscopy Systems Division, FUJIFILM India, shared, “At Fujifilm, we are committed to pushing the boundaries of medical imaging technology to improve patient outcomes. Synapse 3D represents the culmination of years of research and development, and we are thrilled to unveil it at the esteemed ABIP event. This innovative device marks a significant milestone in our journey towards enhancing pulmonary diagnostics and underscores our dedication to advancing healthcare solutions that make a tangible difference in patients' lives.”
With its high-resolution imaging, intuitive navigation, and comprehensive analysis tools, the Synapse 3D Lung Navigation represents a leap forward in pulmonary diagnostics, promising superior diagnostics, treatments, and outcomes for patients worldwide. This groundbreaking technology is poised to revolutionize the way healthcare professionals’ approach respiratory health, ushering in an era of precision in interventional pulmonology and personalized patient care. FUJIFILM India will continue to bring advanced technologies that will be true its commitment of “Value from Innovation.”
More Stories
Qlik’s Accelerating Growth Attracts Significant Investment from Thoma Bravo and ADIA
Golden Eagles Golf Championship Returns for its 8th Edition with Unmatched Glamour, Golf, and Glory with Kapil Dev
Weekend Escapes from Delhi: Uncover Timeless Heritage, Royal Splendor and Scenic Charms